Skip to Main Content

Paper Details

Levels of Alternatively Spliced Tissue Factor in the Plasma of Patients with Pancreatic Cancer May Help Predict Aggressive Tumor Phenotype.
Ann Surg Oncol
19
2015
ACS, Alternatively Spliced, C, CA19-9, DM, Full-length TF, PDAC, Pancreatic Cancer, Patients, TF, Tumor, acute coronary syndrome, alternatively spliced, alternatively spliced TF, antigen 19-9, asTF, cancer, carbohydrate, cardiovascular disease, diabetes, diabetes mellitus, pancreatic cancer, pancreatic ductal adenocarcinoma, pancreatic neuroendocrine tumor, pancreatic tumor, patients, plasma, tissue factor
Acute Coronary Syndrome, Alternative Splicing, Biomarkers, Tumor, Carcinoma, Pancreatic Ductal, Case-Control Studies, Diabetes Mellitus, Enzyme-Linked Immunosorbent Assay, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Pancreatic Neoplasms, Prognosis, Retrospective Studies, Thromboplastin
Author NameAffiliation
Dusten UnruhUniversity of Cincinnati College of Medicine
Farah SaginUniversity of Cincinnati Cancer Institute Tumor Bank, University of Cincinnati College of Medicine
Mariette Adam
Patrick Van Dreden
Barry WoodhamsHaemacon Ltd
Kimberly W HartUniversity of Cincinnati College of Medicine
Christopher J LindsellUniversity of Cincinnati College of Medicine
Syed A AhmadUniversity of Cincinnati College of Medicine
Vladimir Y BogdanovUniversity of Cincinnati College of Medicine
  • 1 - 9

Datasets

Release 1.2